基于“肝脾同治”理论辩治胆固醇性胆囊息肉干预效果与临床经验

Intervention Efficacy and Clinical Experience in Treating Cholesterol Gallbladder Polyps Based on the Theory of “Simultaneous Regulation of Liver and Spleen”

摘要: 胆固醇性胆囊息肉是胆囊息肉样病变中发病率最高的病理类型，占比可达60%以上，其发病与胆固醇代谢紊乱、胆汁胆固醇过饱和密切相关。胆囊息肉(polypoid lesions of gallbladder, PLG)发病率逐年升高并逐渐年轻化，该病的发病人群呈现明确的年轻化倾向，但西医治疗方式较为单一，而中医拥有几千年文化底蕴传承，胆囊息肉的中医治疗已逐步获得临床接受与认可。通过研究分析运用“肝脾同治”理论在临床治疗胆囊息肉的用药规律及辨证分型，为优化临床治疗方案提供参考及思路。

Abstract: Cholesterol gallbladder polyp is the most common pathological type of gallbladder polypoid lesions, accounting for more than 60%, whose pathogenesis is closely related to cholesterol metabolism disorder and bile cholesterol supersaturation. The incidence of gallbladder polyps (polypoid lesions of gallbladder, PLG) has been rising year by year and tends to affect younger populations, and the affected population shows a clear trend toward younger age. Western medicine offers relatively limited therapeutic options, while traditional Chinese medicine (TCM) boasts a heritage of thousands of years. The TCM treatment of gallbladder polyps has gradually gained clinical acceptance and recognition. This paper analyzes the medication rules and syndrome differentiation types in the clinical treatment of gallbladder polyps with the theory of simultaneous regulation of liver and spleen, so as to provide references and ideas for optimizing clinical treatment regimens.